Search alternatives:
mean decrease » a decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
mean decrease » a decrease (Expand Search)
ng decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), teer decrease (Expand Search)
nn decrease » _ decrease (Expand Search), a decrease (Expand Search), gy decreased (Expand Search)
-
281
-
282
-
283
Performance of selected antimalarials against field isolates during the study period.
Published 2024Subjects: -
284
-
285
Performance of selected drugs against field isolates during the study period.
Published 2024Subjects: -
286
-
287
Frequency of SNPs in <i>Pfmrp1</i> gene in field isolates during the study period.
Published 2024Subjects: -
288
<i>In vitro</i> susceptibility responses of field isolates to antimalarials during the study period.
Published 2024Subjects: -
289
-
290
-
291
-
292
-
293
-
294
-
295
Serum VEGF-D levels are elevated at baseline, decrease with sirolimus treatment, and correlate with kidney angiomyolipoma size.
Published 2011“…According to other studies <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379-Glasgow1" target="_blank">[39]</a>, <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379-Young1" target="_blank">[41]</a>, mean serum VEGF-D levels in control female populations are 300–657 ng/ml (indicated by gray box, see additional details in <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0023379#pone.0023379.s013" target="_blank">Table S4</a>, mean VEGF-D levels in control males is not available). …”
-
296
-
297
-
298
-
299
-
300